Physician

Gregory Scott Messenger, MD

According to 2025 Medicare claims, Gregory Messenger, MD (NPI: 1821441486) practices dermatology in the Lansing-East Lansing, MI market, with the plurality of this provider's patient population coming from Ingham, MI. This provider's primary affiliated billing organization is COMPASS HEALTHCARE, PLLC (NPI: 1932533692; TIN: 45-0817179) and primary practice location at 48858-4428. Messenger is affiliated with the Aledade 57 Western Sky MSSP Enhanced (ACO ID: A4756), participating under the MSSP model.

Messenger's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 998 traditional Medicare patients, billed 5,465 HCPCS/CPT codes, and received $311,592 in Medicare payments. The top billing code was 99203 (New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more). Part D data shows 2,277 prescription claims across 862 beneficiaries totaling $1,009,743 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 11 records totaling $258. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $38,558 to $1,009,743. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$156K$312K2020 Medicare payment: $12,524 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $224,072 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $187,372 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $224,663 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $311,592 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
202053218$12,524
20216253,785$224,072
20225643,000$187,372
20236463,396$224,663
20249985,465$311,592

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$505K$1.0M2017 Drug cost: $38,558 (USD; Tot_Drug_Cst)2018 Drug cost: $51,285 (USD; Tot_Drug_Cst)2019 Drug cost: $108,393 (USD; Tot_Drug_Cst)2020 Drug cost: $12,554 (USD; Tot_Drug_Cst)2021 Drug cost: $54,046 (USD; Tot_Drug_Cst)2022 Drug cost: $292,790 (USD; Tot_Drug_Cst)2023 Drug cost: $590,072 (USD; Tot_Drug_Cst)2024 Drug cost: $1,009,743 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
201743132$38,558
201869225$51,285
201957242$108,393
2020100231$12,554
20214861,167$54,046
20225221,172$292,790
20236141,461$590,072
20248622,277$1,009,743

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more209209$67
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more546778$59
11102Biopsy of related skin growth, first growth232263$57
17000Destruction of precancer skin growth, 1 growth311396$38
17003Destruction of precancer skin growth, 2-14 growths2281,473$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab561,484$211,024
Enbrel SureclickEtanercept12336$88,940
Humira(Cf)Adalimumab11308$74,626
OtezlaApremilast13390$58,961
Betamethasone DipropionateBetamethasone Dipropionate34810,005$13,706

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$258SUN PHARMACEUTICAL INDUSTRIES INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gregory Scott Messenger, MD?

Tedicare shows public-source Medicare data for Gregory Scott Messenger, MD (NPI 1821441486), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gregory Scott Messenger, MD have ACO affiliation data?

Gregory Scott Messenger, MD is shown with ACO affiliation data for Aledade 57 Western Sky MSSP Enhanced (MSSP, ACO ID A4756).

What billing organization is linked to Gregory Scott Messenger, MD?

Gregory Scott Messenger, MD is linked to COMPASS HEALTHCARE, PLLC (billing NPI 1932533692) in the available physician profile data.

Does Gregory Scott Messenger, MD have Open Payments data?

Gregory Scott Messenger, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.